Zobrazeno 1 - 10
of 237
pro vyhledávání: '"M. van der Kaaij"'
Publikováno v:
Bijdragen en Mededelingen betreffende de Geschiedenis der Nederlanden. 128(3)
Autor:
Blom, J.C.H.
Publikováno v:
Bijdragen en Mededelingen betreffende de Geschiedenis der Nederlanden, 128(3):review 68. Koninklijk Nederlands Historisch Genootschap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::eeed64839abac27ff5076d038559eb64
https://dare.uva.nl/personal/pure/en/publications/bespreking-van-m-van-der-kaaij-2012-een-eenzaam-staatsman-dirk-de-geer-18701960(df81ed54-2431-4a07-982d-2a334e7c3c61).html
https://dare.uva.nl/personal/pure/en/publications/bespreking-van-m-van-der-kaaij-2012-een-eenzaam-staatsman-dirk-de-geer-18701960(df81ed54-2431-4a07-982d-2a334e7c3c61).html
Autor:
A. Kleijn, J. J. Kloezeman, R. K. Balvers, M. van der Kaaij, C. M. F. Dirven, S. Leenstra, M. L. M. Lamfers
Publikováno v:
Stem Cells International, Vol 2016 (2016)
Serum-free culture methods for patient-derived primary glioma cultures, selecting for glioma stem-like cells (GSCs), are becoming the gold standard in neurooncology research. These GSCs can be implemented in drug screens to detect patient-specific re
Externí odkaz:
https://doaj.org/article/f88954c35f294b5f8a79cfcd0cf2c588
Autor:
J Louwers, B van Hellemondt, Remi Mahmoud, M van der Kaaij, J Schultheiss, Bas Oldenburg, P van Boeckel, Herma H. Fidder, Bindia Jharap, Nofel Mahmmod
Publikováno v:
Journal of Crohn's and Colitis. 15:S420-S422
Background Globally, the prevalences of both inflammatory bowel diseases (IBD) and obesity have increased over the past decades. Recently, obesity has been linked to treatment failure in anti-TNF-treated patients with inflammatory bowel disease (IBD)
Autor:
J Schultheiss, J Louwers, P van Boeckel, Herma H. Fidder, Bindia Jharap, Bas Oldenburg, Nofel Mahmmod, B van Hellemondt, M van der Kaaij, Remi Mahmoud
Publikováno v:
Journal of Crohn's and Colitis. 15:S327-S328
Background Inflammatory bowel disease (IBD) is often managed with anti-tumour necrosis factor-α (anti-TNFα) compounds, but only few studies have reported on long-term outcomes. We aimed to determine whether the incidence of loss-of-response decreas
Autor:
Jildou M van der Kaaij, Martin Feelisch, Edward Gilbert-Kawai, Jonny Coppel, Denny Z. H. Levett, Jo Court, Michael P.W. Grocott, Daniel Martin, A. Vercueil, Monty G. Mythen
Publikováno v:
Journal of Applied Physiology. 122:1011-1018
Anecdotal reports suggest that Sherpa highlanders demonstrate extraordinary tolerance to hypoxia at high altitude, despite exhibiting lower arterial oxygen content than acclimatized lowlanders. This study tested the hypothesis that Sherpas exposed to
Publikováno v:
Amylase. 1:1-11
Fibronectin type III (FNIII) domains were first identified in the eukaryotic plasma protein fibronectin, where they act as structural spacers or enable protein-protein interactions. Recently we characterized two large and multi-domain amylases in Mic
Autor:
Bas Oldenburg, J Schultheiss, B van Hellemondt, M van der Kaaij, Remi Mahmoud, Bindia Jharap, J Louwers, Nofel Mahmmod, P van Boeckel, Herma H. Fidder
Publikováno v:
Journal of Crohn's and Colitis. 15:S109-S109
Background Combination therapy with anti-TNF compounds and immunomodulators (IMM; thiopurine or methotrexate) is superior to IMM or anti-TNF monotherapy in patients with inflammatory bowel disease (IBD). IMMs are frequently discontinued during the ma
Publikováno v:
Febs Journal, 283(12):13745, 2354-2368. NLM (Medline)
Microbacterium aurum B8.A is a bacterium that originates from a potato starch-processing plant and employs a GH13 α-amylase (MaAmyA) enzyme that forms pores in potato starch granules. MaAmyA is a large and multi-modular protein that contains a novel
Autor:
Martine L.M. Lamfers, M. Van Der Kaaij, Anne Kleijn, Sieger Leenstra, Clemens M F Dirven, Jenneke Kloezeman, Rutger K. Balvers
Publikováno v:
Stem Cells International
Stem Cells International, Vol 2016 (2016)
Stem Cells International, Vol 2016 (2016)
Serum-free culture methods for patient-derived primary glioma cultures, selecting for glioma stem-like cells (GSCs), are becoming the gold standard in neurooncology research. These GSCs can be implemented in drug screens to detect patient-specific re